Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial. Liu Y, Yao L, Kalhor N, Carter BW, et al. Lung Cancer 2022;174:112-117.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Y, Yao L, Kalhor N, Carter BW, et al. Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial. Lung Cancer 2022;174:112-117.
PMID: 36371941